The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 03, 2024
Filed:
May. 24, 2019
Applicant:
Nantomics, Llc, Culver City, CA (US);
Inventors:
Andrew Nguyen, Culver City, CA (US);
John Zachary Sanborn, Culver City, CA (US);
Stephen Charles Benz, Culver City, CA (US);
Assignee:
NantOmics, LLC, Culver City, CA (US);
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
G16B 20/30 (2019.01); A61K 39/00 (2006.01); C12Q 1/70 (2006.01); G16B 35/00 (2019.01); G16C 20/60 (2019.01); G16H 10/40 (2018.01); G16H 20/10 (2018.01); G16H 20/40 (2018.01); G16H 70/60 (2018.01);
U.S. Cl.
CPC ...
G16B 20/30 (2019.02); A61K 39/0011 (2013.01); C12Q 1/708 (2013.01); G16B 35/00 (2019.02); G16C 20/60 (2019.02); G16H 10/40 (2018.01); G16H 20/10 (2018.01); G16H 20/40 (2018.01); G16H 70/60 (2018.01); A61K 39/00 (2013.01); C12Q 2600/106 (2013.01); C12Q 2600/156 (2013.01);
Abstract
Contemplated antiviral/cancer treatments comprise analysis of neoepitopes from viral DNA that has integrated into the host genome, and design of immunotherapeutic agents against such neoepitopes.